The “Consecutive Combined Test”—using Double test from week 8 + 0 and Nuchal Translucency Scan, for first trimester screening for Down Syndrome

This publication has 18 references indexed in Scilit:

• First-Trimester or Second-Trimester Screening, or Both, for Down's Syndrome
  New England Journal of Medicine, 2005
• Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies
  American Journal of Obstetrics and Gynecology, 2005
• Multicenter study of first‐trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk‐orientated two‐stage first‐trimester screening
  Ultrasound in Obstetrics & Gynecology, 2005
• The first trimester ‘combined test’ for the detection of Down syndrome pregnancies in 4939 unselected pregnancies
  Prenatal Diagnosis, 2002
• Absence of nasal bone in fetuses with trisomy 21 at 11–14 weeks of gestation: an observational study
  The Lancet, 2001
• Time for total shift to first-trimester screening for Down's syndrome
  The Lancet, 2001
• Alpha-fetoprotein in plasma and serum of healthy adults: preanalytical, analytical and biological sources of variation and construction of age-dependent reference intervals
  Scandinavian Journal of Clinical and Laboratory Investigation, 2001
• First-trimester screening for Down syndrome using nuchal translucency measurement with free β-hCG and PAPP-A between 10 and 13 weeks of pregnancy—the combined test
  Prenatal Diagnosis, 1999
• First‐trimester screening for fetal aneuploidy: biochemistry and nuchal translucency
  Ultrasound in Obstetrics & Gynecology, 1997
• Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha‐fetoprotein level
  BJOG: An International Journal of Obstetrics and Gynaecology, 1987